<DOC>
	<DOCNO>NCT00001314</DOCNO>
	<brief_summary>In study researcher plan perform diagnostic test call transesophageal echocardiography order see record movement function heart . Transesophageal echocardiography similar upper gastrointestinal endoscopy . Different view heart take small , flexible instrument position esophagus ( tube connects mouth stomach ) . This allow doctor create clear picture heart wall esophagus rather outside body muscle , fat , bone chest wall . During transesophageal echocardiography picture heart take patient rest patient receive medication call dobutamine . Dobutamine medication make heart beat strong faster , similar exercise heart . Researchers particularly interested study patient defect valve heart , especially aortic regurgitation mitral regurgitation . Patients defect heart valve tend develop abnormality size function leave ventricle . The left ventricle one four chamber heart responsible eject blood heart circulation . Researchers believe identify change function heart muscle , may able predict occurrence muscle damage due diseased valve . The purpose study determine whether function heart muscle measure dobutamine stress transesophageal echocardiography predict later development problem function size leave ventricle .</brief_summary>
	<brief_title>Investigation Heart Function Patients With Heart Valve Defects</brief_title>
	<detailed_description>In investigation , propose perform dobutamine stress transesophageal echocardiography patient aortic regurgitation patient mitral regurgitation order ass myocardial contractile reserve . The purpose study determine whether contractile reserve myocardium measure dobutamine stress echocardiography predictor development subsequent leave ventricular dysfunction leave ventricular dilatation , well recovery leave ventricular function surgery , patient .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>18 65 year age . Patients severe aortic regurgitation patient severe mitral regurgitation . Patients discontinue medication 48 hour prior study . Women must pregnant . Patients must associate valvular heart disease ( i.e. , patient aortic regurgitation exclude coexistent mitral valve disease ; patient mitral regurgitation exclude coexistent aortic valve disease ) . Patients must form cardiomyopathy . Patients must coronary artery disease . Patients must ventricular ectopy baseline condition ( i.e. , couplet , frequent PVc 's [ great 6/min ] , early coupling [ `` RonT '' phenomenon ] , ventricular bigeminy ) might potentially predispose patient development dangerous dysrhythmia dobutamine infusion . Patients must history cardiac arrest ventricular tachycardia . Patients must history congestive heart failure . Patients must hypotension ( i.e. , systolic blood pressure le 100 mmHg ) . Patients must systolic blood pressure great 200 mmHg . Patients must leave atrial size great 100 mm . Patients must atrial fibrillation . Patients must sinus tachycardia great equal 100 beats/min . Patients must esophageal disease . Patients must medical condition , discretion physician charge , may increase risk procedure .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2000</verification_date>
	<keyword>Aortic Regurgitation</keyword>
	<keyword>Dobutamine Stress</keyword>
	<keyword>Left Ventricular Function</keyword>
	<keyword>Mitral Regurgitation</keyword>
	<keyword>Myocardial Contractile Reserve</keyword>
	<keyword>Transesophageal Echocardiography</keyword>
</DOC>